Methotrexate in the Treatment of Axial Spondyloarthritis

NCT00298012 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Spondylarthropathies
Spondylitis, Ankylosing

Interventions

DRUG: Methotrexate

Sponsor

Rheumatism Foundation Hospital

Collaborators

[object Object]